Je. Karp et al., AIDS-RELATED KAPOSIS-SARCOMA - A TEMPLATE FOR THE TRANSLATION OF MOLECULAR PATHOGENESIS AND TARGETED THERAPEUTIC APPROACHES, Hematology/oncology clinics of North America, 10(5), 1996, pp. 1031
AIDS-related Kaposi's sarcoma (KS) represents a complex interaction of
host and viral factors. There are a number of fundamental questions s
urrounding the interplay between the disparate factors that can contri
bute to the pathogenesis and pathophysiology of this disease. Targets
such as the enhancement of immune function, inhibition of angiogenic f
actors or immunostimulatory cytokines, inhibition of viral proteins su
ch as Tat, or hormonal manipulations are now or will in the future bec
ome the focus of research to develop innovative anti-KS therapy and pr
evention measures. Antiviral approaches aimed at HIV or other viruses
may potentially target a number of steps in KS pathogenesis. This arti
cle reviews diverse modalities-cytotoxic, antiviral, gene-directed, gr
owth factor-targeted, and antiangiogenesis-that singly, or more likely
in combination, stand to make an impact on the cure and prevention of
AIDS-related KS.